Recent pharmaceutical interventions, especially GLP-1RAs, have advanced treatment for glycemic control and obesity
Participants self-reported general dietary habits, including changes in food preferences since the start of GLP-1RA therapy
Morton says
Clinical trials have shown these medications can help protect the heart, kidneys, and liver
This growing role makes it essential for NPs to understand the full scope of GLP-1RA indications, benefits, and risks to ensure safe, effective, and equitable care
All types of substance addictions are clinically codified as substance use disorder, which is considered a chronic disease characterized by a transition from recreational drug use to compulsive and disordered use